Document is current
Any future updates will be listed below
-
Authors
Iyyanki, Tejaswi
Zhang, Baozhen
Wang, Qixuan
Hou, Ye
Jin, Qiushi
Xu, Jie
Yang, Hongbo
Liu, Tingting
Wang, Xiaotao
Song, Fan
Luan, Yu
Yamashita, Hironobu
Chien, Ruby
Lyu, Huijue
Zhang, Lijun
Wang, Lu
Warrick, Joshua
Raman, Jay D.
Meeks, Joshua J.
DeGraff, David J.
Yue, Feng https://orcid.org/0000-0002-7954-5462
-
Funding
Funding for this research was provided by:
National Institute of General Medical Sciences (1R35GM124820)
National Human Genome Research Institute (R01HG009906)
National Cancer Institute (U01CA200060)
National Institute of Diabetes and Digestive and Kidney Diseases (R24DK106766)
American Cancer Society (RSG1723301TBE)
- License Information
-
More Information
Article History
Received: 18 April 2020
Accepted: 25 March 2021
First Online: 15 April 2021
Declarations
:
: Bladder tumor samples were obtained from Penn State Hershey, College of Medicine’s biobank storage at the Institute of Personalized Medicine (IPM) with appropriate protocol approval from the institutional review board (IRB Number: STUDY00001117). The samples were also obtained from Northwestern University with proper approval from the institutional board (IRB number: STU00088853). All patients had previously provided written informed consent for tumor collection and subsequent analysis. This study was performed in compliance with the Helsinki Declaration.
: The authors declare no competing interests.
